IP Library Granted Patent US 7,846,683
Granted Patent B2
US 7,846,683 · App. 11/575,887 · Granted Dec 7, 2010

Method for identifying agents which modulate cell growth or survival

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,683
App. No.
11/575,887
Granted
Dec 7, 2010
Kind
B2
Abstract

The present invention relates to a method for identifying an agent. for modulating cell growth or survival. The method involves the identification of an agent which modulates the net ratio of nuclear-localized versus cytosolic-localized H11 kinase or mutant H11 kinase in a cell. A method for diagnosing a cancer associated with H11 kinase or Akt activation in a subject is also provided.

Claims (11)

1. A method for identifying an agent for increasing cardiac cell survival comprising:

a) contacting a first cardiac cell containing H11 kinase with a test agent;

b) determining the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in said first cell;

c) determining the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in a second cardiac cell that has not been contacted with said test agent; and

d) comparing the difference between the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in the first cell as compared with the second cell wherein an increase in said ratio in the first cell as compared to the ratio in the second cell indicates that the test agent increases cardiac cell survival.

2. A method for identifying an agent for increasing cardiac cell survival comprising:

a) contacting a first cardiac cell containing H11 kinase encoded by the nucleic acid of

SEQ ID NO:2 or 3 with a test agent;

b) determining the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in said first cell;

c) determining the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in a second cardiac cell that has not been contacted with said test agent; and

comparing the difference between the net ratio of nuclear-localized versus cytosolic-localized H11 kinase in the first cell as compared with the second cell, wherein an increase in said ratio in the first cell as compared to the ratio in the second cell indicates that the test agent increases cardiac cell survival.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 5, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031170/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2007
From: VATNER, STEPHEN F.; DEPRE, CHRISTOPHER
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 019924/0118 →